Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Clinical trial NCT00735917 · COMPLETED

Trial details

NCT number: NCT00735917
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer

Start date: 2008-10-01
Primary completion: 2011-04-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.